Iodinated radiographic contrast media possess antioxidant properties in vitro

Acta Radiologica

Volumn 46, Issue 8, 2005, Pages 815-822

  Berg, K ^a   Skarra, S ^a   Bruvold, M ^a   Brurok, H ^a   Karlsson, J O G ^a   Jynge, P ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Antioxidant properties; IRCM; Total antioxidant status

Indexed keywords

ANTIOXIDANTS; ASSAYS; FREE RADICAL REACTIONS; HYDROXYLATION; MEDICAL APPLICATIONS;

ANTIOXIDANT PROPERTIES; IRCM; TOTAL ANTIOXIDANT STATUS;

RADIOGRAPHY;

ACETYLCHOLINESTERASE; CONTRAST MEDIUM; FENTON'S REAGENT; HYDROGEN PEROXIDE; IODOBENZOIC ACID DERIVATIVE; IRON; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ARTICLE; CHEMISTRY; COLORIMETRY; DRUG INTERACTION; IN VITRO STUDY; OXIDATION REDUCTION REACTION; SYNTHESIS;

ACETYLCHOLINESTERASE; COLORIMETRY; CONTRAST MEDIA; DRUG INTERACTIONS; HYDROGEN PEROXIDE; IRON; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; TRIIODOBENZOIC ACIDS; XANTHINE OXIDASE;

EID: 30844457743     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850500336224     Document Type: Article

References (45)

1. Almén T. Visipaque - a step forward. A historical review. Acta Radiol 1995;36:2-18.
2. Almén T, Golman K. Contrast media pharmacokinetics in the assessment of renal failure. In: Parvez Z, Moncada R, Sovak M, editors. Contrast media: biologic effects and clinical application. Florida: CRC Press; 1985. p. 77.
3. Andrew E, Berg KJ. Nephrotoxic effects of X-ray contrast media. J Toxicol Clin Toxicol 2004;42:325-32.
4. Aspelin P, Aubrey P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
5. Bae KT, Hong C, Whiting BR. Radiation dose in multidetector row computed tomography cardiac imaging. J Magn Reson Imaging 2004; 19:859-63.
6. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990;258:F115-20.
7. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998;58:319-25.
8. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-87.
9. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39: 1113-19.
10. Cracowski JL, Devillier P, Durand T, Stanke-Labesque F, Bessard G. Vascular biology of the isoprostanes. J Vase Res 2001;38:93-103.
11. Darr D, Zarilla KA, Fridovich T. A mimic of Superoxide dismutase activity based upon desferrioxamine B and manganese(IV). Arch Biochem Biophys 1987;258:351-5.
12. Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W Jr, Vlietstra RE, et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000;101:2172-7.
13. Dawson P, Edgerton D. Contrast media and enzyme inhibition. I. Cholinesterase. Br J Radiol 1983;56:653-6.
14. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002;89:356-8.
15. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
16. Floyd RA, Watson JJ, Wong PK. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Meth 1984; 10:221-35.
17. Gillbe CE, Sage FJ, Gutteridge JM. Commentary: mannitol: molecule magnifique or a case of radical misinterpretation? Free Radic Res 1996;24:1-7.
18. Goldstein S, Czapski G. Mannitol as an OH. scavenger in aqueous solutions and in biological systems. Int J Radiat Biol Relat Stud Phys Chem Med 1984;46:725-9.
19. Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-6.
20. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000:36:1542-8.
21. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endotheliumderived vascular relaxing factor. Nature 1986;320: 454-6.
22. Hutcheson IR, Griffith TM, Pitman MR, Towart R, Gregersen M, Refsum H, et al. Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 1999;128:451-7.
23. Karlsson JOG. Preclinical safety assessment of contrast media: predictive value. Eur Radiol 1996;Suppl 2:S3.
24. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-8.
25. Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32:64-71.
26. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997;204:297-312.
27. Krause W, Niehues D. Biochemical characterization of X-ray contrast media. Invest Radiol 1996;31:30-42.
28. Lasser EC, Lang JH. Inhibition of acetylcholinesterase by some organic contrast media. A preliminary communication. Invest Radiol 1966;1:237-42.
29. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Colch) 1993;84:407-12.
30. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
31. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-7.
32. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
33. Mugge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 1991;260:C219-25.
34. Nikolsky E, Mehran R. Understanding the consequences of contrast-induced nephropathy. Rev Cardiovasc Med 2003;Suppl 5:S10.
35. Onodera T, Ashraf M. Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent. J Mol Cell Cardiol 1991;23: 365-70.
36. Parvez Z, Rahman MA, Moncada R. Contrast media-induced lipid peroxidation in the rat kidney. Invest Radiol 1989;24:697-702.
37. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vase Biol 1997;17:2309-15.
38. Pitman MR, Karlsson JOG, Griffith TM. Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta. Br J Pharmacol 1996;119:685-90.
39. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-7.
40. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998;53:230-42.
41. Spitz DR, Oberley LW. An assay for Superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
42. Stokes KY, Granger DN. Role of nitric oxide in ischemia-reperfusion injury. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. p. 633.
43. Strube M, Haenen GR, van den Berg H, Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997;26:515-21.
44. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
45. Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992; 41:1008-15.